Idenix Pharmaceuticals News

News on Idenix Pharmaceuticals (Ticker: IDIX) continually updated from thousands of sources around the net.

Friday May 11 | Seeking Alpha

Idenix Will Move Up On Promising New Data In 2013

With so many pharmaceutical companies developing and testing new Hepatitis C drug treatments lately, investors may find it difficult to keep up.

Comment?

Mon May 07, 2012

Seeking Alpha

Idenix Pharmaceuticals' CEO Presents at Deutsche Bank 37th Annual Healthcare Conference

Next we have Idenix Pharmaceuticals, and we have the President and CEO, Ron Renaud, future Hep C/Cystic Fibrosis Company.

Comment?

Related Topix: Biotech, Healthcare Industry

Mon Apr 30, 2012

The Motley Fool

Rating Wall Street's Ratings: Procter & Gamble, Idenix Pharmaceuticals, Kaiser Aluminum, Citizens Re

Earnings season brings on a flurry of upgrades and downgrades, and it can be an all-day affair just to get through them all.

Comment?

Digital Producer

Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

Idenix Pharmaceuticals, Inc., announced today that Idenix management will present a corporate overview at the Deutsche Bank 37th Annual Healthcare Conference on May 7, 2012 at 3:30 p.m. EDT at the Intercontinental Hotel, Boston and at the Bank of America Merrill Lynch Global Health Care Conference on May 15, 2012 at 1:40 p.m. PDT at the Wynn ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cambridge, MA

AmericanBankingNews.com

Idenix Pharmaceuticals Upgraded by JMP Securities

A number of other analysts have also recently weighed in on IDIX. Analysts at Credit Suisse initiated coverage on shares of Idenix Pharmaceuticals in a research note to investors on Tuesday, April 17th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry